tiprankstipranks
Trending News
More News >
Kobayashi Pharmaceutical Co Ltd (KBYPF)
OTHER OTC:KBYPF
US Market

Kobayashi Pharmaceutical Co (KBYPF) Ratios

Compare
6 Followers

Kobayashi Pharmaceutical Co Ratios

KBYPF's free cash flow for Q4 2024 was ¥0.49. For the 2024 fiscal year, KBYPF's free cash flow was decreased by ¥ and operating cash flow was ¥0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.11 2.82 3.34 3.59 3.28
Quick Ratio
2.59 2.43 3.00 3.29 3.00
Cash Ratio
1.10 1.27 1.86 1.87 1.56
Solvency Ratio
0.19 0.42 0.44 0.43 0.42
Operating Cash Flow Ratio
0.00 0.33 0.62 0.44 0.48
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 22.42K 1.85K
Net Current Asset Value
¥ 92.57B¥ 95.67B¥ 114.96B¥ 124.93B¥ 108.44B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.24 1.31 1.29 1.29 1.31
Debt Service Coverage Ratio
747.50 911.24 1.33K 1.20K 661.32
Interest Coverage Ratio
1.08K 888.97 1.48K 1.45K 1.24K
Debt to Market Cap
0.00 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
11.69 13.40 10.50 8.29 9.07
Net Debt to EBITDA
-2.38 -2.10 -3.00 -3.07 -2.59
Profitability Margins
Gross Profit Margin
52.47%55.56%55.53%57.18%56.65%
EBIT Margin
9.16%15.90%16.82%17.81%17.71%
EBITDA Margin
12.70%19.40%19.17%19.83%19.88%
Operating Profit Margin
15.01%14.86%16.04%16.79%17.24%
Pretax Profit Margin
8.40%15.89%16.81%17.80%17.70%
Net Profit Margin
6.08%11.73%12.04%12.70%12.76%
Continuous Operations Profit Margin
6.08%11.73%12.04%12.70%12.76%
Net Income Per EBT
72.35%73.80%71.64%71.34%72.10%
EBT Per EBIT
55.97%106.90%104.80%106.03%102.67%
Return on Assets (ROA)
3.79%7.60%7.83%7.81%8.06%
Return on Equity (ROE)
4.83%9.93%10.12%10.08%10.52%
Return on Capital Employed (ROCE)
11.35%12.20%13.07%12.91%13.78%
Return on Invested Capital (ROIC)
8.21%8.99%9.35%9.20%9.93%
Return on Tangible Assets
4.11%8.27%8.26%8.22%8.51%
Earnings Yield
2.38%3.95%2.88%2.79%1.95%
Efficiency Ratios
Receivables Turnover
3.35 3.27 3.47 2.82 2.85
Payables Turnover
5.36 4.45 8.17 7.15 8.63
Inventory Turnover
3.26 3.49 4.18 4.40 4.61
Fixed Asset Turnover
2.46 3.64 4.78 6.89 7.23
Asset Turnover
0.62 0.65 0.65 0.61 0.63
Working Capital Turnover Ratio
1.79 1.55 1.32 1.27 1.35
Cash Conversion Cycle
152.79 134.11 147.65 161.57 164.93
Days of Sales Outstanding
108.85 111.49 105.06 129.65 128.11
Days of Inventory Outstanding
112.06 104.56 87.28 82.95 79.09
Days of Payables Outstanding
68.12 81.95 44.69 51.02 42.28
Operating Cycle
220.91 216.06 192.34 212.60 207.21
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 242.08 413.81 286.96 306.87
Free Cash Flow Per Share
0.00 63.17 203.38 233.40 253.79
CapEx Per Share
0.00 178.91 210.43 53.57 53.08
Free Cash Flow to Operating Cash Flow
0.00 0.26 0.49 0.81 0.83
Dividend Paid and CapEx Coverage Ratio
0.00 0.88 1.40 2.15 2.41
Capital Expenditure Coverage Ratio
0.00 1.35 1.97 5.36 5.78
Operating Cash Flow Coverage Ratio
0.00 18.60 40.30 35.59 34.86
Operating Cash Flow to Sales Ratio
0.00 0.11 0.19 0.14 0.16
Free Cash Flow Yield
0.00%0.93%2.25%2.58%2.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
42.50 25.32 34.78 35.82 51.32
Price-to-Sales (P/S) Ratio
2.58 2.97 4.19 4.55 6.55
Price-to-Book (P/B) Ratio
2.00 2.51 3.52 3.61 5.40
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 107.49 44.40 38.73 49.69
Price-to-Operating Cash Flow Ratio
0.00 28.05 21.82 31.50 41.09
Price-to-Earnings Growth (PEG) Ratio
-37.49 7.69 12.09 13.24 76.85
Price-to-Fair Value
2.00 2.51 3.52 3.61 5.40
Enterprise Value Multiple
17.96 13.21 18.86 19.87 30.36
Enterprise Value
EV to EBITDA
17.70 13.21 18.86 19.87 30.36
EV to Sales
2.25 2.56 3.61 3.94 6.03
EV to Free Cash Flow
0.00 92.76 38.31 33.56 45.78
EV to Operating Cash Flow
0.00 24.21 18.83 27.29 37.86
Tangible Book Value Per Share
2.59K 2.42K 2.39K 2.34K 2.17K
Shareholders’ Equity Per Share
2.87K 2.70K 2.57K 2.50K 2.34K
Tax and Other Ratios
Effective Tax Rate
0.28 0.26 0.28 0.29 0.28
Revenue Per Share
2.23K 2.29K 2.16K 1.99K 1.93K
Net Income Per Share
135.42 268.16 259.61 252.35 245.70
Tax Burden
0.72 0.74 0.72 0.71 0.72
Interest Burden
0.92 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.08 0.05 0.05 0.05 0.05
SG&A to Revenue
-0.09 0.17 0.03 0.03 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.90 1.14 0.81 0.90
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis